Pharma
Cambridge and AstraZeneca extend programme to support PhD students
Cambridge and AstraZeneca are extending their longstanding and highly successful PhD programme, the latest chapter in a partnership that has already supported nearly 200 early-career scientists. ...
ROAR Events Agency appoints Alex Goldie to business development team
Cambridge agency expands its business development team with a focus on technology and life sciences clients CAMBRIDGE, UK, 12 October 2026 - ROAR Events Agency has appointed Alex Goldie to its business development team to develop new client relationships and support the agency's growth...
Shared Party Night – Christmas 2026
An Après-Ski Christmas Celebration! This Christmas, swap the boardroom for the slopes and join us for an unforgettable Après-Ski celebration! ROAR Events Agency invites you to experience the magic of the mountains at our spectacular Shared Christmas Party Night, taking place on Friday...
Guardtech gearing up for an action-packed 2026 exhibition finale
The contamination control specialists prepare for a busy autumn schedule across Healthcare, Pharmaceutical and Biotechnology events. ...
ELRIG Protein Sciences in Drug Discovery
Free to attend
ELRIG and The Protein Society announce keynote speakers for protein sciences in Drug Discovery 2026
• Prof Dame Carol Robinson (University of Oxford), Dr Andrew Doré (Isomorphic Labs) and Prof Paula Booth (King’s College London) to lead event taking place from 10–11 November at GSK Stevenage • Programme to focus on AI, machine learning and data-driven approaches across protein design...
Cresset launches Flare AI Client, helping computational chemists complete hours of work in minutes
Scientists can now connect company-approved AI providers such as Claude Code and GitHub Copilot directly to Flare, helping teams set up, execute, and analyze complex computational chemistry workflows in minutes not hours. ...
Group A Streptococcus: vaccines are now back on the agenda
VacZine Analytics, a specialist publisher in vaccines, has released a new independent commercial forecast for Group A Streptococcus (GAS) vaccines, now that two industry candidates have entered clinical trials. ...
Milner Seminar: Focus on neurodegeneration
Milner Seminars are designed to facilitate interdisciplinary connections. Seminars include speakers from both academia and industry/biotech, each addressing a common theme, and are followed by networking over refreshments. ...
AstraZeneca announces strategic equity investment and clinical collaboration with Summit Therapeutics to advance leading ADC combination strategy in cancer
Clinical collaboration will evaluate sonesitatug vedotin, a Claudin-18.2 ADC, with ivonescimab, a first-in-class PD-1/VEGF bispecific, in gastrointestinal cancers ...